What is ELV's health score?

Elevance Health, Inc. (ELV) has a TradeApes health score of 60 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ELV's estimated fair value?

Based on our 5-year discounted cash flow model, Elevance Health, Inc.'s estimated fair value is $390.78 per share, representing a -0.6% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ELV undervalued or overvalued?

Our model currently rates ELV as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ELV... Refresh in a moment for the full analysis.

Elevance Health, Inc. (ELV)

Financials Fair Value medium healthy

$393.19

Updated: 2026-05-30

TradeApes Score

Financial Strength

70 Healthy

Operating Trend

30 Weak

Relative Value

65 Healthy

Capital Allocation

80 Strong

Risk

70 Healthy

Est. Fair Value $390.78

DCF Upside -0.6%

Sector Rank #4883 of 6235

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Revenue declining — sales down 5–15% year over year

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.